Literature DB >> 27581662

Intratumor and circulating clonal heterogeneity shape the basis of precision breast cancer therapy.

Demosthenes E Ziogas1,2, John Spiliotis3, Efstathios G Lykoudis4, Georgios C Zografos5, Dimitrios H Roukos1,6,7.   

Abstract

Entities:  

Keywords:  breast cancer; clonal diversity; intratumor heterogeneity; next-generation sequencing; therapy

Mesh：

Year:  2016        PMID： 27581662     DOI： 10.2217/fon-2016-0307

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  1 in total

1.  Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies.

Authors:  Regina C Betz; Silke Redler; Evgeniya Denisova; Dana Westphal; Harald M Surowy; Friedegund Meier; Barbara Hutter; Julia Reifenberger; Arno Rütten; Alexander Schulz; Mildred Sergon; Mirjana Ziemer; Benedikt Brors
Journal:  Cancer Gene Ther       Date:  2021-05-27       Impact factor: 5.854
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.